Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration

Raoul, Jean-Luc; Hansten, Philip D.

doi:10.1016/j.ctrv.2024.102794

Cancer Treatment Reviews

2024

DOI: 10.1016/j.ctrv.2024.102794

|View full text |Cite

Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration

Jean-Luc Raoul,

Philip D. Hansten

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 99 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Pascal's uncertainty principle: Managing drug–drug interactions when the risks are unclear

Hansten,

Gomez‐Lumbreras,

Villa‐Zapata

et al. 2024

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Therapeutic decision‐making (TDM) often occurs under conditions of scientific uncertainty, including decisions on how to manage the majority of drug–drug interactions (DDIs). The existence of many DDIs is not firmly established, and there is an unfortunate tendency to make decisions based on the binary assessment of whether or not a particular DDI is real, rather than taking a more probabilistic and holistic approach to TDM. There also seems to be an undue fear of making a Type I error (assuming the DDI is real when it is not) while ignoring the often much greater risk of a Type II error (assuming the DDI is not real, when it is). Thus, a more rational TDM process for such DDIs is needed. In his famous “Wager,” philosopher‐mathematician Blaise Pascal made a probabilistic argument for believing in God. Instead of considering probability in isolation, Pascal linked the probability of God's existence with the severity of the outcome (an eternity in Hell for non‐believers) and also added a third factor—the ease with which the risk can be avoided. We propose a novel paradigm for TDM that uses all three of Pascal's steps: probability, severity, and avoidability. We present several specific DDI examples to demonstrate how Pascal's Uncertainty Principle can help pharmacists make clinical management decisions for these DDIs. We suggest that this process be called “Pascal's Uncertainty Principle” rather than “Pascal's Wager,” because it can be used to make rational decisions in the presence of uncertainty in many non‐theological situations. This process reinforces the value of philosophical training for pharmacy students.

show abstract

Pascal's uncertainty principle: Managing drug–drug interactions when the risks are unclear

Hansten,

Gomez‐Lumbreras,

Villa‐Zapata

et al. 2024

J Am Coll Clin Pharm

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration

Cited by 1 publication

References 99 publications

Pascal's uncertainty principle: Managing drug–drug interactions when the risks are unclear

Pascal's uncertainty principle: Managing drug–drug interactions when the risks are unclear

Contact Info

Product

Resources

About